TW200718434A - Method for producing granular oral composition with oligosaccharide solution - Google Patents

Method for producing granular oral composition with oligosaccharide solution

Info

Publication number
TW200718434A
TW200718434A TW095117132A TW95117132A TW200718434A TW 200718434 A TW200718434 A TW 200718434A TW 095117132 A TW095117132 A TW 095117132A TW 95117132 A TW95117132 A TW 95117132A TW 200718434 A TW200718434 A TW 200718434A
Authority
TW
Taiwan
Prior art keywords
oral composition
oligosaccharide
oral
solution
oligosaccharide solution
Prior art date
Application number
TW095117132A
Other languages
Chinese (zh)
Inventor
Setsu Ijichi
Mieko Matsuoka
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Publication of TW200718434A publication Critical patent/TW200718434A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

To provide a method for producing a granular oral composition with an oligosaccharide solution as a binder, by which a powdery oral material can be formed (granulated) without a binder except the oligosaccharide to provide the granular oral composition giving good oral touch, when the powdery oral material is suspended in a liquid and not suspended in a liquid. This method for producing the granular oral composition with the oligosaccharide as the binder is characterized by dissolving the oligosaccharide in a spraying solution for a fluidized bed granulation method and then spraying the solution on the powdery oral material.
TW095117132A 2005-05-31 2006-05-15 Method for producing granular oral composition with oligosaccharide solution TW200718434A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005158628A JP2006335648A (en) 2005-05-31 2005-05-31 Method for producing granular oral composition with oligosaccharide solution

Publications (1)

Publication Number Publication Date
TW200718434A true TW200718434A (en) 2007-05-16

Family

ID=37481399

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095117132A TW200718434A (en) 2005-05-31 2006-05-15 Method for producing granular oral composition with oligosaccharide solution

Country Status (5)

Country Link
JP (1) JP2006335648A (en)
KR (1) KR20080011389A (en)
CN (1) CN1872342A (en)
TW (1) TW200718434A (en)
WO (1) WO2006129468A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4758974B2 (en) * 2007-11-05 2011-08-31 旭化成ケミカルズ株式会社 Acidic milk beverage
JP4600853B2 (en) * 2007-12-21 2010-12-22 日本薬品開発株式会社 Condensate-containing granule derived from young wheat leaves, granule and method for producing the same
JP5324943B2 (en) * 2008-01-30 2013-10-23 サントリーホールディングス株式会社 Method for producing granular food composition by fluidized bed granulation
JP6523164B2 (en) * 2013-04-26 2019-05-29 サントリーホールディングス株式会社 Composition comprising fructo-oligosaccharide and quercetin glycoside
JP6910185B6 (en) * 2017-04-13 2021-10-20 雄二 松川 Parasympathetic-dominant lymphocyte-activating antitumor agent and its manufacturing method
JP6910200B6 (en) * 2017-05-12 2021-10-20 雄二 松川 Parasympathetic nerve predominance by absorption of upper gastrointestinal mucosa Lymphocyte activation Upper gastrointestinal mucosa absorption Antineoplastic agent
JP2019201629A (en) * 2018-05-17 2019-11-28 大正製薬株式会社 Solid material
KR102364023B1 (en) * 2021-04-29 2022-02-17 주식회사 셀로닉스 Method for producing granular formulation prebiotics using fructooligosaccharides without additives
CN117462602B (en) * 2023-12-27 2024-03-29 深圳保时健生物工程有限公司 Probiotic complexing agent and preparation method and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3505367B2 (en) * 1997-09-10 2004-03-08 三菱化学フーズ株式会社 Sweetener composition
JP2000336354A (en) * 1999-03-19 2000-12-05 Sanei Gen Ffi Inc Anti-fading agent
JP2002218945A (en) * 2001-01-25 2002-08-06 Toyo Shinyaku:Kk Dietary fiber-containing food and method for forming the same and binder to be used for the method
JP2005124587A (en) * 2001-12-28 2005-05-19 Toyo Shinyaku:Kk Granulated material of kale dry powder and method for producing the same
JP2005102639A (en) * 2003-10-01 2005-04-21 Marutomo Co Ltd Constipation improving food and method for producing the same
JP2005295840A (en) * 2004-04-08 2005-10-27 Yoshio Minamitani Healthy devil's tongue

Also Published As

Publication number Publication date
KR20080011389A (en) 2008-02-04
WO2006129468A1 (en) 2006-12-07
JP2006335648A (en) 2006-12-14
CN1872342A (en) 2006-12-06

Similar Documents

Publication Publication Date Title
TW200718434A (en) Method for producing granular oral composition with oligosaccharide solution
TN2009000093A1 (en) Pharmaceutical compositions comprising nilotinib or its salt
MX2009001945A (en) Acid-impregnated activated carbon and methods of forming and using the same.
TW200727791A (en) Materials and methods for improving livestock productivity
EP1928802B8 (en) Powder redispersible in water, process for production thereof and use thereof
SI1896364T1 (en) Pulverulent lime composition, method for the production thereof, and use of the same
NZ595071A (en) Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide
TW200714392A (en) Silver-copper composite powder having silver microparticule attached thereto, and method of production of the silver-copper composite powder
WO2010003078A3 (en) Melt granulation process
ZA200902558B (en) Process for producing modified polymer, modified polymer obtained by the process, and rubber composition containing the same
RS50812B (en) Dry granulated composition comprising emtricitabine and tenofovir df
EP1898267A4 (en) Process for production of liquid developer, and liquid developer produced by the process
EP1898268A4 (en) Process for production of liquid developer, and liquid developer produced by the process
PL2020864T3 (en) Compressed gum and process for the preparation thereof
GB201021170D0 (en) Granulated organopolysiloxane products
DE502007001036D1 (en) METHOD FOR PRODUCING SHAPED PARTS FROM CORK PARTICLES
ATE508782T1 (en) PSA PROCESS USING A COMPOSITE ADSORPTION BED WITH AN ADSORPTION AGENT AND PCM AGGLOMERATES
WO2007061938A3 (en) Systems and methods for liquid dosing
TWI347960B (en) Process for the production of mouldings from a mixture of particulate natural materials and thermoplastic binder
FR2930265B1 (en) PROCESS FOR THE AGGLOMERATION OF INDUSTRIAL DUST, IN PARTICULAR BY A BRIQUETTING TECHNIQUE
PL1842900T3 (en) Detergent Tablets
SG165196A1 (en) Method of producing dietary fiber-containing health food
WO2011015950A3 (en) Agglomerated particulate lignosulfonate
MX2009004557A (en) Dry granulated pharmaceutical compositions and methods for producing same.
ZA200307410B (en) Process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent, salts of ranelic acid and their hydrates.